Nanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chu, Dinh-Toi | - |
dc.contributor.author | Thi, Hue Vu | - |
dc.contributor.author | Nguyen, Tiep Tien | - |
dc.contributor.author | Vu, Thuy-Duong | - |
dc.contributor.author | Thi, Yen Vy Nguyen | - |
dc.contributor.author | Mani, Indra | - |
dc.contributor.author | Gohil, Nisarg | - |
dc.contributor.author | Bhattacharjee, Gargi | - |
dc.contributor.author | Ramakrishna, Suresh | - |
dc.contributor.author | Singh, Vijai | - |
dc.date.accessioned | 2023-11-14T08:26:35Z | - |
dc.date.available | 2023-11-14T08:26:35Z | - |
dc.date.created | 2023-10-11 | - |
dc.date.issued | 2023-09 | - |
dc.identifier.issn | 2352-9520 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/192230 | - |
dc.description.abstract | Metabolic disorders result from inborn and acquired dysfunction of organs and tissues that are responsible for producing energy in the body. These diseases are now among the most prevalent maladies in the world. Treatment often requires addressing individual conditions, including obesity, diabetes, and liver diseases with a combination of multiple drugs. Accumulating evidence shows that the defects or overexpression of some specific genes in the diseased organ cause such diseases. Therefore, advanced options are required to control them at the molecular level. In this review, we highlight the current approaches of nanotechnologies, especially for delivering exogenous nucleic acid nanoparticles to treat metabolic disorders. We also summarize the mechanisms of how various nucleic acid nanoparticles have been utilized, the trends, and the potential applications of these materials in metabolic disorders. Greater knowledge of nanotechnologies and nucleic acid particles may pave the way to cure these prevalent diseases effectively. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Elsevier Inc. | - |
dc.title | Nanotechnology and nucleic acid nanoparticles for treatment of metabolic disorders | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ramakrishna, Suresh | - |
dc.identifier.doi | 10.1016/j.onano.2023.100181 | - |
dc.identifier.scopusid | 2-s2.0-85172465279 | - |
dc.identifier.bibliographicCitation | OpenNano, v.13, pp.1 - 10 | - |
dc.relation.isPartOf | OpenNano | - |
dc.citation.title | OpenNano | - |
dc.citation.volume | 13 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordPlus | alpha actin | - |
dc.subject.keywordPlus | antisense oligonucleotide | - |
dc.subject.keywordPlus | atorvastatin | - |
dc.subject.keywordPlus | carbon nanotube | - |
dc.subject.keywordPlus | cholesterol | - |
dc.subject.keywordPlus | collagen type 1 | - |
dc.subject.keywordPlus | curcumin | - |
dc.subject.keywordPlus | Ginger extracted nanoparticle | - |
dc.subject.keywordPlus | gold nanoparticle | - |
dc.subject.keywordPlus | graphene oxide | - |
dc.subject.keywordPlus | high density lipoprotein | - |
dc.subject.keywordPlus | hydrogel | - |
dc.subject.keywordPlus | iron oxide nanoparticle | - |
dc.subject.keywordPlus | lipoplex | - |
dc.subject.keywordPlus | liposome | - |
dc.subject.keywordPlus | low density lipoprotein | - |
dc.subject.keywordPlus | messenger RNA | - |
dc.subject.keywordPlus | metformin | - |
dc.subject.keywordPlus | mevinolin | - |
dc.subject.keywordPlus | microRNA | - |
dc.subject.keywordPlus | nanocapsule | - |
dc.subject.keywordPlus | nanocarrier | - |
dc.subject.keywordPlus | nanoparticle | - |
dc.subject.keywordPlus | nitric oxide | - |
dc.subject.keywordPlus | nucleic acid | - |
dc.subject.keywordPlus | plasmid DNA | - |
dc.subject.keywordPlus | poly lactic co glycolic acid | - |
dc.subject.keywordPlus | polymer | - |
dc.subject.keywordPlus | pravastatin | - |
dc.subject.keywordPlus | protein kinase | - |
dc.subject.keywordPlus | querceti | - |
dc.subject.keywordPlus | resveratrol | - |
dc.subject.keywordPlus | Salacia chinensis containing gold nanoparticle | - |
dc.subject.keywordPlus | silica nanoparticle | - |
dc.subject.keywordPlus | silver nanoparticle | - |
dc.subject.keywordPlus | simvastatin | - |
dc.subject.keywordPlus | small interfering RNA | - |
dc.subject.keywordPlus | superparamagnetic iron oxide | - |
dc.subject.keywordPlus | thymoquinone | - |
dc.subject.keywordPlus | tissue inhibitor of metalloproteinase 1 | - |
dc.subject.keywordPlus | titanium dioxide | - |
dc.subject.keywordPlus | triacylglycerol | - |
dc.subject.keywordPlus | unclassified drug | - |
dc.subject.keywordPlus | amputation | - |
dc.subject.keywordPlus | anisotropy | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | atherosclerosis | - |
dc.subject.keywordPlus | biocompatibility | - |
dc.subject.keywordPlus | bloating | - |
dc.subject.keywordPlus | blood pressure | - |
dc.subject.keywordPlus | bone disease | - |
dc.subject.keywordPlus | burn | - |
dc.subject.keywordPlus | cancer therapy | - |
dc.subject.keywordPlus | cardiovascular disease | - |
dc.subject.keywordPlus | coronary artery disease | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | diabetic wound | - |
dc.subject.keywordPlus | drug combination | - |
dc.subject.keywordPlus | dr | - |
dc.subject.keywordAuthor | Gene delivery system | - |
dc.subject.keywordAuthor | Gene therapy | - |
dc.subject.keywordAuthor | Metabolic disorders | - |
dc.subject.keywordAuthor | Non-viral gene vectors | - |
dc.subject.keywordAuthor | Nucleic acid nanoparticles | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S2352952023000609?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.